S. 4225
116th Congress
Senate
Safeguarding Therapeutics Act of 2020
Official title: A bill to establish authority to destroy counterfeit devices offered for import, and for other purposes.
Health
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationFraud offenses and financial crimes
More subjectsShow fewer subjects
Health technology, devices, suppliesPrescription drugsProduct safety and quality
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 20, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 20, 2020
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Plain-English summary
Safeguarding Therapeutics Act of 2020
This bill authorizes the Food and Drug Administration to destroy imported counterfeit medical devices.
Related & companion bills
3
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cosponsors
3
Cite this page
U.S. Congress. (2026). S. 4225: Safeguarding Therapeutics Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-4225/
"S. 4225: Safeguarding Therapeutics Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-4225/.
S. 4225, 116th Cong. (2026), https://openamerica.io/bill/116-S-4225/.
[S. 4225: Safeguarding Therapeutics Act of 2020](https://openamerica.io/bill/116-S-4225/)